Potassium Carbonate → HCID 25008810, compound
Reaction equation
[NH2:1][C:2]1[N:7]=[CH:6][C:5]([CH2:8][C@@H:9]([O:31][C:32]([N:34]2[CH2:39][CH2:38][CH:37]([N:40]3[CH2:46][CH2:45][C:44]4[CH:47]=[CH:48][CH:49]=[CH:50][C:43]=4[NH:42][C:41]3=[O:51])[CH2:36][CH2:35]2)=[O:33])[C:10]([N:12]2[CH2:17][CH2:16][CH:15]([N:18]3[CH2:23][CH2:22][N:21](C(OC(C)(C)C)=O)[CH2:20][CH2:19]3)[CH2:14][CH2:13]2)=[O:11])=[CH:4][C:3]=1[CH3:52].C([O-])([O-])=O.[K+].[K+]>Cl.CN(C=O)C>[O:51]=[C:41]1[N:40]([CH:37]2[CH2:36][CH2:35][N:34]([C:32]([O:31][C@H:9]([CH2:8][C:5]3[CH:6]=[N:7][C:2]([NH2:1])=[C:3]([CH3:52])[CH:4]=3)[C:10](=[O:11])[N:12]3[CH2:17][CH2:16][CH:15]([N:18]4[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]4)[CH2:14][CH2:13]3)=[O:33])[CH2:39][CH2:38]2)[CH2:46][CH2:45][C:44]2[CH:47]=[CH:48][CH:49]=[CH:50][C:43]=2[NH:42]1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 75 mg (0.10 mmol) of tert-butyl 4-(1-{(R)-3-(6-amino-5-methyl-pyridin-3-yl)-2-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carbonyloxy]-propionyl}-piperidin-4-yl)-piperazine-1-carboxylate (Example 114) in 5 mL 2 M HCl was stirred for 20 h at RT. After lyophilisation of the reaction mixture the residue was dissolved in 1 mL DMF, made alkaline with 0.6 mL saturated K2CO3 solution and purified by HPLC. The fractions containing the product were combined and again lyophilised.
Workup
- custompurified by HPLC
- additionThe fractions containing the product
Sources & evidence
- ORD record
- ord-689ea57c53ab483689a20736425ea4c0
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07696196B2
Reaction notes
Loading…